Alpine Immune Sciences — Company Overview, News & Financial Data

Alpine Immune Sciences (NASDAQ:ALPN) is a biotechnology company focused on discovering and developing innovative therapies to modulate the immune system, targeting cancer, autoimmune disorders, and other diseases. With a versatile platform, Alpine is advancing a pipeline of unique candidates designed to engage the immune system through multiple mechanisms. The company's projects leverage its proprietary technologies to create potentially transformative treatments that aim to improve patient outcomes significantly. Alpine Immune Sciences is committed to pushing the boundaries of immunotherapy, striving for breakthroughs that can address unmet medical needs and improve the lives of patients worldwide.